It always happens. As calmer heads prevail and political reality sets in, the radicals are tossed under the bus. The radicals, in turn, fulminate and issue press releases that border on hysteria.
Thus:
By Jim O'Sullivan,
Catherine Williams, and Michael Norton
STATE HOUSE NEWS SERVICE
SAN DIEGO, JUNE 18, 2008......A controversial Senate plan to forbid
gifts from pharmaceutical companies to health care workers appears
unlikely to survive intact, as Massachusetts state leaders have caught
an earful from industry executives while attending an international
biotechnology convention this week.
The plan's leading proponent, Senate President Therese Murray, said
researchers have told her the ban would prevent productive interactions
between doctors and researchers who are trying to treat the same
diseases.
"It's something that we didn't discuss when we did it, because we were
looking purely at gifts to doctors," Murray said in a telephone
interview with the News Service. "But the fact is that some of these
companies do bring researchers and doctors together to go over the
latest research."
"Through what we did, in their explaining, there are many things they
won't be able to do that are important to science," she said.
www.statehousenews.com
Whatever that means...
Meanwhile, the Prescription Project backed CEJA recommendations Report 1 of The Council on Ethical and Judicial Affairs: Industry Support of Professional Education in Medicine were soundly rejected Which led Daniel Carlat to become completely unhinged and attack Medscape and George Lundberg as a CME tool. Very mature. carlatpsychiatry.blogspot.com/
And on the heels of the resounding defeat the munchkins at the Association of American Medical Colleges had to issue a press release re-cycling the release of a study on CME which had to acknowledge there limited evidence of bias in CME or that sampling has any influence on prescribing practices. Then there is the underlying assumption that industry-based research is defacto corrupt, tainted and incorrect and information coming from centralized academic sources is pure. Yeah, right.
Can't wait to take this one on.
Thus:
By Jim O'Sullivan,
Catherine Williams, and Michael Norton
STATE HOUSE NEWS SERVICE
SAN DIEGO, JUNE 18, 2008......A controversial Senate plan to forbid
gifts from pharmaceutical companies to health care workers appears
unlikely to survive intact, as Massachusetts state leaders have caught
an earful from industry executives while attending an international
biotechnology convention this week.
The plan's leading proponent, Senate President Therese Murray, said
researchers have told her the ban would prevent productive interactions
between doctors and researchers who are trying to treat the same
diseases.
"It's something that we didn't discuss when we did it, because we were
looking purely at gifts to doctors," Murray said in a telephone
interview with the News Service. "But the fact is that some of these
companies do bring researchers and doctors together to go over the
latest research."
"Through what we did, in their explaining, there are many things they
won't be able to do that are important to science," she said.
www.statehousenews.com
Whatever that means...
Meanwhile, the Prescription Project backed CEJA recommendations Report 1 of The Council on Ethical and Judicial Affairs: Industry Support of Professional Education in Medicine were soundly rejected Which led Daniel Carlat to become completely unhinged and attack Medscape and George Lundberg as a CME tool. Very mature. carlatpsychiatry.blogspot.com/
And on the heels of the resounding defeat the munchkins at the Association of American Medical Colleges had to issue a press release re-cycling the release of a study on CME which had to acknowledge there limited evidence of bias in CME or that sampling has any influence on prescribing practices. Then there is the underlying assumption that industry-based research is defacto corrupt, tainted and incorrect and information coming from centralized academic sources is pure. Yeah, right.
Can't wait to take this one on.
